Lab Automation (TTA AND TLA) Market Size, Share, Growth and Industry analysis, By Type (Task Targeted Automation (TTA), Total Laboratory Automation (TLA)), By Application (Medical and Pharmaceutical Lab, Biology and Chemistry Lab) and Regional Forecast to 2034

• 

  Request a Free sample to learn more about this report

LAB AUTOMATION (TTA AND TLA) MARKET OVERVIEW

The global lab automation (tta and tla) market size was valued at USD 13.57 billion in 2025 and is expected to reach USD 27.51 billion by 2034, growing at a compound annual growth rate (CAGR) of about 8.17% from 2025 to 2034.

The United States Lab Automation (TTA AND TLA) Market size is projected at USD 4.45649 Billion in 2025, the Europe Lab Automation (TTA AND TLA) Market size is projected at USD 3.78205 Billion in 2025, and the China Lab Automation (TTA AND TLA) Market size is projected at USD 3.44686 Billion in 2025.

A multidisciplinary approach to research, development, optimization, and use of laboratory technologies that support new and enhanced procedures is laboratory automation. Task Targeted Automation (TTA) and Total Laboratory Automation (TLA) are the two types of lab automation (TLA). With TTA, a module will carry out particular process duties, such sorting and decapping. The samples must then be carried manually to the various analyzers, returned for post-analytics, and then placed in the refrigerator rooms. All of these steps take time and require human interaction.

Additionally, they have an impact on traceability because TTA samples occasionally sit dormant for a while. All of that is different with TLA solutions; all you have to do is load the samples in the format you need (in racks or bulk), and the TLA solution takes care of the rest. The samples are selectively prepared; as necessary, they are decapped, centrifuged, sent to the appropriate analyzers, sealed, stored, and disposed of as needed. By eliminating redundant, low-value tasks, this system also improves traceability, allowing you to know exactly where every sample has been and what has occurred to it along the route. Naturally, higher standards and more efficient resource use have a direct, favorable effect on patient safety and business results.

KEY FINDINGS

COVID-19 IMPACT

Halt on Manufacturing Operations to Slower Market Growth

The COVID-19 pandemic is the main factor affecting the lab automation (TTA and TLA) market for nowadays. In addition, the lab automation (TTA AND TLA) market saw a considerable decline in production as a result of the drop in laborers due to social distance rules during the COVID-19 pandemic. Due to supply chain challenges and restricted access to sites as a result of the COVID-19 epidemic, the majority of projects in China, the US, Germany, and South Korea are behind schedule. During the COVID-19 pandemic, the lab automation (TTA and TLA) market saw a drop in its market share. This is explained by the substantial decline in the industrial, automotive, and construction sectors.

LATEST TRENDS

Improved Lab Efficiency to Boost Market Growth

Growth in the lab automation (TTA and TLA) market is anticipated to be fueled by increased consumer desire to improve lab efficiency, boost capacity, and lower error. Clinical laboratories are always working to provide better services by speeding up turnaround and raising the caliber of their output. By offering consistency, thorough quality control, and fewer manual procedures, TLA helps labs solve these obstacles and, as a result, greatly improves laboratory performance. Clinical chemistry and haematology laboratories are the most prevalent users of TLA systems, with clinical microbiology usage increasing.

• According to CDC government source — about 14 billion lab tests are ordered each year across 266,000+ CLIA-certified labs in the U.S., intensifying demand for end-to-end automation of pre-analytical, analytical, and post-analytical phases.

• Peer-reviewed implementations report 86% fewer manual processing steps after TLA, and process TAT reductions up to 87.3% (HIV) and 19.3% (COVID) when lean methods are combined with automation—quantifying why TLA/TTA is being prioritized in high-throughput labs.

Request a Free sample to learn more about this report

LAB AUTOMATION (TTA AND TLA) MARKET SEGMENTATION

By Type Analysis

As per the type, the market is classified as follows: Task Targeted Automation (TTA) and Total Laboratory Automation (TLA). The most lucrative lab automation (TTA and TLA) market share is anticipated to be Total Laboratory Automation (TLA).

By Application Analysis

Based on application, the market is segmented as follows: Medical and Pharmaceutical Lab, Biology and Chemistry Lab, and Other Laboratories. Additionally, the biotechnology and pharmaceutical industries are anticipated to be the most lucrative application area in lab automation (TTA and TLA) market share.

DRIVING FACTORS

Benefits of Automating Laboratory Procedures to Facilitate Market Development

Automating laboratory procedures increases the overall effectiveness of experimental operations by accelerating tasks, decreasing waste, requiring fewer reagents, and enabling faster throughput of experiments. The running costs of the laboratory are decreased when these elements are merged. These elements should drive the lab automation (TTA and TLA) market forward. Automated technologies can also increase laboratory safety by using automated techniques to handle and store dangerous compounds. As a result, these risky reagents and operations are better avoided by laboratory staff. Automated technologies can also increase laboratory safety by using automated techniques to handle and store dangerous compounds. As a result, these risky reagents and operations are better avoided by laboratory staff.

• According to U.S. BLS government source — labs face ~24,200 technologist/technician openings each year (2023–2033) with employment projected to rise 5%, pushing labs toward TTA/TLA to sustain throughput with fewer hands.

• According to CDC government source — with 14 billion tests/year used in many medical decisions, programs that improve traceability/standardization (which TLA supports) are a priority for regulators and public-health agencies.

Increased Productivity due to Lab Automation (TTA and TLA) to Promote Industry Progress

The laboratory world was interested in Task Targeted Automation because they were seeking for ways to increase productivity. The need for cost reduction is well understood by laboratory managers, and they are starting to understand that reallocating workers would have a bigger impact on their bottom line than reducing reagent prices by a few cents per test. Reduced turnaround times, decreased exposure to biohazards, increased staff productivity, improved sample tracking, effective archiving, and increased job satisfaction are all anticipated benefits of lab automation (TTA and TLA), all of which will improve patient care. In turn, this is anticipated to fuel the lab automation (TTA and TLA) market growth.

RESTRAINING FACTORS

High Maintenance Costs to Hinder Market Growth

However, the lab automation (TTA and TLA) market is constrained by a lack of planning for technological advancement, the fact that small- to medium-sized labs do not prioritize automation, and the absence of clear standards for data exchange and communication. The cost of maintenance is also high which is a major restraining factor of the lab automation (TTA and TLA) market.

• According to European Commission government sources — transition deadlines were formally extended in 2024; e.g., Class D IVDs must comply by 31 Dec 2027 and Class C by 31 Dec 2028, prolonging dual-framework compliance and documentation burdens that slow new TLA/TTA rollouts.

• According to European Commission/agency analyses — multiple EUDAMED modules became available 2020–2021 and are projected to become mandatory by late 2025–2026 (actor/device, NB & certificates, market surveillance/vigilance), adding data-capture and UDI integration tasks to automation projects.

• Request a Free sample to learn more about this report

•  

LAB AUTOMATION (TTA AND TLA) MARKET REGIONAL INSIGHTS

Increase in Demand to Propel Market Progress in North America

During the projection period, North America is anticipated to be the most profitable area for lab automation (TTA and TLA) market. Sales of lab automation devices are rising as a result of the rising demand for clinical diagnostic processes. Because of the existence of major pharmaceutical corporations, there has been an increase in investment in the drug discovery and genomics markets. Major product manufacturers are expanding their distribution networks and manufacturing capacities to increase their penetration into emerging markets. A profitable potential for lab automation (TTA and TLA) is presented by this. The lab automation (TTA and TLA) market for is anticipated to grow as a result.

KEY INDUSTRY PLAYERS

Market Players Focus on New Product Launches to Strengthen Market Position

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.   

• Autobio — Chinese IVD manufacturer expanding automation lines to address documented throughput/TAT gains (published up to 87.3% TAT reduction in targeted processes); opportunity lies in scaling such gains into high-volume chemistry/immuno labs processing thousands/day.

• Beckman Coulter — Beckman’s high-throughput front-ends align with BLS government-reported staffing pressures (~24,200 openings/year) and with peer-reviewed TLA evidence showing 86% step reduction, underpinning business cases for sample-to-result automation.

List of Top Lab Automation (TTA AND TLA) Companies

• BD
• Inpeco
• Autobio
• Siemens Healthineers
• IDS Co.,Ltd
• Beckman Coulter
• Roche
• Abbott (GLP Systems)

REPORT COVERAGE

The report covers overall market aspects, including the market segmentation based on its type and application. The report depicts a diverse group of participants that includes the market and the potential market leaders. Major factors that are expected to drive major growth in the market. The factors anticipated to expand the market share are also included in the report to offer market insights. The estimated growth of the market in the forecast period is also included in the report. The regional analysis is completed to explain the region's dominance in the global market. The factors hindering the growth of the market are discussed in detail. The SWOT analysis of the market is depicted in the report. It contains all-inclusive market details.